INSIGHT

How Life Sciences Companies Can Optimize Their Supply Chains

Sarah Weaver, Michael VanderKlugt • September 23, 2026

Industries: Life Sciences

---

Supply chain management has never been simple for life sciences companies. Between shifting regulatory requirements, global sourcing risks, and the pressure to control costs without cutting corners, the margin for error is narrow. A single disruption can ripple through the entire operation, whether it’s a supplier going dark, an unexpected life sciences industry policy change, or an unexpected recall.

The companies that handle these challenges best aren’t just reacting faster. They’ve built supply chains with quality and resilience built in from the start. This article covers the key areas life sciences companies should focus on to tighten their supply chain operations and reduce their exposure to disruption.  

Quality Has to Come First 

Quality has to be the organizing principle behind every supply chain decision a life sciences company makes. That means building quality touch points into procurement, receiving, inventory management, and dispositioning so that problems surface early rather than late. Good manufacturing practice (GMP) compliance is the baseline.

GMP standards require that trading partners are qualified, risks are assessed, and documentation is visible and traceable throughout the supply chain. Companies that treat GMP as a checkbox exercise tend to scramble when something goes wrong. Companies that genuinely embed it into daily operations are better positioned to catch issues before they become costly ones. 

Supplier Diversification Is a Risk Management Tool 

Relying on a single supplier for critical raw materials is a structural vulnerability. If that vendor faces production issues, shipping delays, or its own regulatory problems, your operations absorb the consequences directly. Diversifying your supplier network gives you options and room to shift when the business needs it. 

That means building a strategic sourcing model that balances cost, quality, and risk. Companies should evaluate where single-source dependencies exist and develop qualified backup suppliers before a disruption forces the decision. For nonmanufacturing needs, like research supplies, office materials, and similar categories, a centralized procurement strategy helps standardize quality and capture savings across departments.

Technology Needs to Connect the Dots 

Most life sciences companies manage their supply chains through an enterprise resource planning (ERP) system. That’s table stakes. The harder work is making sure the technology integrates across functions and provides real-time visibility into what’s happening across the supply chain. FDA computer software validation requirements add another layer of complexity. Any supply chain activities tied to an ERP system require documented validation to demonstrate quality and compliance. That work needs to happen before an audit, not in response to one. 

Beyond compliance, the companies seeing real operational improvement are those connecting their ERP with demand planning tools, inventory optimization systems, and scenario modeling capabilities. Rather than relying on static reports, when these systems talk to each other, teams can: 

• run through trade-offs 
• simulate disruptions 
• make decisions with more confidence 

Inventory Management Deserves More Attention Than It Gets 

Excess inventory ties up cash. Too little inventory creates service risk. Getting this right requires more than a gut feel for order quantities, it requires real digital visibility across the supply chain and demand planning tools that reflect how the business operates. 

Sharing demand forecasts with trading partners is one of the more underused practices in the industry. When suppliers understand what you’re planning, they can prepare accordingly, which reduces the risk of capacity shortfalls and last-minute scrambles. 

Cost Visibility Is Part of Supply Chain Strategy 

Regulatory changes like the Inflation Reduction Act have put additional pressure on biopharma companies to control costs throughout the supply chain. But you can’t manage what you can’t see. Many companies don’t have a full accounting of their supply chain costs – from sourcing and manufacturing to shipping, tariffs, and returns.

Building that visibility strengthens your supply chain strategy by giving leadership a clearer picture of where costs are coming from and where changes in the business environment will create the most pressure. Getting your arms around total supply chain costs also improves decision-making when: 

• evaluating new suppliers 
• entering new markets 
• responding to regulatory shifts 

Breaking Down the Silos 

Supply chain can’t function as a separate department with its own information and its own priorities. Procurement, warehouse operations, finance, and quality teams all touch the supply chain, and when they’re not aligned, inefficiencies build up and problems fall through the cracks. 

Strong cross-functional communication isn’t a soft skill, it’s an operational requirement. Companies that build supply chain coordination into their regular business rhythms, rather than treating it as an exception process, tend to handle disruptions more smoothly when they arrive. 

Working With BPM  

BPM works with companies across the life sciences industry, including biopharma, medtech, and biotech, to address the financial and operational challenges that come with managing a complex supply chain. From deploying data analytics and agentic AI to automation, our team brings the technical knowledge and industry context to help companies build supply chain operations that can hold up under scrutiny.

If your supply chain strategy hasn’t kept pace with your company’s growth or the current regulatory environment, contact us.